PHILADELPHIA--(BUSINESS WIRE)--TransCelerate BioPharma Inc. today announced the availability of an enhanced technology enabled Common Protocol Template (CPT). This update to the CPT is in alignment ...
Version numbers start at "1.0.0" when the protocol is first completed and will increase when changes that impact the outcome of the procedure are made (patches: 1.0.1 ...
The final version of the Therapeutic Products Directorate (TPD) and Biologic and Genetic Therapies Directorate (BGTD) Protocol Safety and Efficacy Assessment Template-Clinical Trial Application (PSEAT ...